Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells
2018 · BMC Cancer · 19 citations
https://doi.org/10.1186/s12885-018-4588-y
N
Nobuhito Taniki
Keio University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
78
Papers
1.6K
Citations
17
h-index
27
i10-index
Nobuhito Taniki is an academic researcher from Keio University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Diseases and Immunity & Liver Disease and Transplantation. The author has an h-index of 17, co-authored 67 publications.
ORCID: 0000-0003-3627-5412Papers by this author
worksAcetaldehyde exposure underlies functional defects in monocytes induced by excessive alcohol consumption
2021 · Scientific Reports · 16 citations
https://doi.org/10.1038/s41598-021-93086-y
Clinical implications with tolvaptan on monitored bioimpedance-defined fluid status in patients with cirrhotic ascites: an observational study
2020 · BMC Gastroenterology · 11 citations
https://doi.org/10.1186/s12876-020-01205-2
Efficacy and Safety of Deep Sedation in Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma
2019 · Advances in Therapy · 5 citations
https://doi.org/10.1007/s12325-018-0865-z
Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma
2024 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-024-61611-4
TCA cycle, amino acid metabolism, and the urea cycle.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0094460.g007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat